The Thai News
Published by Mark Andrew Santiago
Thailand continues to use Sinovac after occurrence of neurologic side effect similar to cerebro vascular accident.
Bangkok - Thailand will continue to use China's covid-19 vaccine - Sinovac Biotech ( SVA.O) after reports of 6 occurrences of peculiar side effects similar to stroke among recipients, health experts said on Wednesday.
Six health care workers from the province of Rayong east of Bangkok who were inoculated earlier this month experience symptoms similar to cerebro vascular accidents including lethargy and hemiparesis of extremities, the panel of experts said.
There were no blood clots found after series of diagnostic procedures were carried out among recipients and eventually restored physiologic functions after few sessions of therapy.
The announcement comes amid heightened global focus on efficacy and side-effects from different covid-19 vaccines, and temporary suspensions in some countries, including over reports of blood clots among recipients.
Sinovac didn't respond immediately on an email requesting for comment.
Thailand has received more than two million doses of China's Sinovac Biotech that have been administered to more than 600,000 individuals in the country. It has ordered 1.5 million shots due to arrive soon.
Health experts could not determine the cause of the unusual neurologic symptoms which they concluded that they were related to the nervous system but were not fatal, said Kulkanya Chokephaibulk of Bangkok's Siriraj Hospital.
Brain scan were done among six recipients that showed negative results and occurrences of CVA ( stroke ) was ruled out, and no irregularities were found in the batch of the vaccine where the six doses originated. Kulkanya said.
Doses from the same batch of vaccine have been distributed to other provinces and more than 300,000 people may have received the shots, and no such effects have been previously reported, she added.
No comments:
Post a Comment